Bellicum Announces Interim Results Showing Low Rates of Cancer Recurrence in Pediatric AML Patients Treated with BPX-501

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/16/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. DVLT
10. ADYYF

Go back to Bellicum Announces Interim Results Showing Low Rates of Cancer Recurrence in Pediatric AML Patients Treated with BPX-501
(NASDAQ: BLCM) Delayed: 0.62 --0 (-0%)
Previous Close $0.62    52 Week High $23.84 
Open $115.62    52 Week Low $7.24 
Day High $0.62    P/E N/A 
Day Low $0.62    EPS $0.00 
Volume 224,873